Company context
BioNTech Digital prompts can include culture, product, and business context from this profile.
Role targeting
Pair this profile with an open role to generate focused behavioral and technical questions.
Answer coaching
Practice responses, get feedback, and refine stories before applying or interviewing.
BioNTech SE is a global immunotherapy company headquartered in Mainz, Germany, that is pioneering the development of next-generation treatments for cancer and other serious diseases. Founded on the principle of translating complex scientific research into life-saving therapies, the company has become a world leader in mRNA technology. By leveraging a deep understanding of the human immune system, BioNTech aims to create highly personalized treatments that target specific disease markers, moving away from a one-size-fits-all approach to medicine.
BioNTech’s mission is to translate science into survival, with a vision to improve the health of people worldwide by combining fundamental research and operational excellence to develop innovative immunotherapies and vaccines.
Founded
2008
Headquarters
Mainz, Germany
Employees
6,000+
Industry
Biotechnology
Opportunity to work on cutting-edge, life-saving medical technology.
High level of investment in research and development and AI integration.
High-pressure environment due to the fast-paced nature of clinical trials.
Complex organizational structure following rapid global expansion.
Revenue
€3.8 billion (2023)
Funding
Publicly Traded (NASDAQ: BNTX)
CEO
Ugur Sahin